Endo International plc (ENDPQ)
| Previous close | 0.0013 |
| Open | 0.0010 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's range | 0.0010 - 0.0025 |
| 52-week range | 0.0002 - 0.1450 |
| Volume | |
| Avg. volume | 123,476 |
| Market cap | 588,050 |
| Beta (5Y monthly) | 1.12 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.0700 |
| Earnings date | 04 Mar 2024 - 08 Mar 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
PR NewswireEndo Launches Unscripted Video Series With Real Peyronie's Disease Patients
Endo International plc (OTC: ENDPQ) announced today the launch of its new branded video series, PD Pool Hall, which aims to educate people about Peyronie's disease (PD), a men's health condition that is estimated to affect 1 in 10 men in the U.S.* and can lead to a curvature deformity of the penis when erect.
- PR Newswire
Endo Announces Five Presentations at the Sexual Medicine Society of North America (SMSNA) Annual Meeting
Endo International plc (OTC: ENDPQ) announced today that five new presentations related to Peyronie's disease, or PD, and XIAFLEX® (collagenase clostridium histolyticum, or CCH, injection 0.9 mg) will be shared during the Sexual Medicine Society of North America (SMSNA) annual meeting, taking place November 16-19 in San Diego.
- PR Newswire
ENDO REPORTS THIRD-QUARTER 2023 FINANCIAL RESULTS
Endo International plc (OTC: ENDPQ) today reported financial results for the third-quarter ended September 30, 2023.
